Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 282

1.

The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancers.

Barrett MT, Lenkiewicz E, Malasi S, Basu A, Yearley JH, Annamalai L, McCullough AE, Kosiorek HE, Narang P, Wilson Sayres MA, Chen M, Anderson KS, Pockaj BA.

Breast Cancer Res. 2018 Jul 11;20(1):71. doi: 10.1186/s13058-018-1004-0.

PMID:
29996881
2.

JAK2 and PD-L1 Amplification Enhance the Dynamic Expression of PD-L1 in Triple-negative Breast Cancer.

Chen M, Pockaj B, Andreozzi M, Barrett MT, Krishna S, Eaton S, Niu R, Anderson KS.

Clin Breast Cancer. 2018 May 26. pii: S1526-8209(17)30780-2. doi: 10.1016/j.clbc.2018.05.006. [Epub ahead of print]

PMID:
29933930
3.

Platination of cysteine by an epidermal growth factor receptor kinase-targeted hybrid agent.

Yang M, Wu H, Chu J, Gabriel LA, Kim Y, Anderson KS, Furdui CM, Bierbach U.

Chem Commun (Camb). 2018 Jul 11;54(54):7479-7482. doi: 10.1039/c8cc04251a. Epub 2018 Jun 19.

PMID:
29915817
4.

A compact, low-cost, quantitative and multiplexed fluorescence detection platform for point-of-care applications.

Obahiagbon U, Smith JT, Zhu M, Katchman BA, Arafa H, Anderson KS, Blain Christen JM.

Biosens Bioelectron. 2018 Apr 4;117:153-160. doi: 10.1016/j.bios.2018.04.002. [Epub ahead of print]

5.

Eccrine Sweat as a Biofluid for Profiling Immune Biomarkers.

Katchman BA, Zhu M, Blain Christen J, Anderson KS.

Proteomics Clin Appl. 2018 Jun 8:e1800010. doi: 10.1002/prca.201800010. [Epub ahead of print]

PMID:
29882373
6.

An Automated Microfluidic Assay for Photonic Crystal Enhanced Detection and Analysis of an Antiviral Antibody Cancer Biomarker in Serum.

Race CM, Kwon LE, Foreman MT, Huang Q, Inan H, Kesiraju S, Le P, Lim SJ, Smith AM, Zangar RC, Demirci U, Anderson KS, Cunningham BT.

IEEE Sens J. 2018 Feb 15;18(4):1464-1473. doi: 10.1109/JSEN.2017.2777529. Epub 2017 Nov 24.

PMID:
29881332
7.

Pre-diagnostic dynamic HPV16 IgG seropositivity and risk of oropharyngeal cancer: Methodologic issues.

Anderson KS, Mork J, Langseth H, Wallstrom G.

Oral Oncol. 2018 May;80:93. doi: 10.1016/j.oraloncology.2018.02.013. Epub 2018 Mar 30. No abstract available.

PMID:
29606498
8.

Insights into DNA substrate selection by APOBEC3G from structural, biochemical, and functional studies.

Ziegler SJ, Liu C, Landau M, Buzovetsky O, Desimmie BA, Zhao Q, Sasaki T, Burdick RC, Pathak VK, Anderson KS, Xiong Y.

PLoS One. 2018 Mar 29;13(3):e0195048. doi: 10.1371/journal.pone.0195048. eCollection 2018.

9.

Activity and fidelity of human DNA polymerase α depend on primer structure.

Baranovskiy AG, Duong VN, Babayeva ND, Zhang Y, Pavlov YI, Anderson KS, Tahirov TH.

J Biol Chem. 2018 May 4;293(18):6824-6843. doi: 10.1074/jbc.RA117.001074. Epub 2018 Mar 19.

PMID:
29555682
10.

Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation.

Kaaks R, Fortner RT, Hüsing A, Barrdahl M, Hopper M, Johnson T, Tjønneland A, Hansen L, Overvad K, Fournier A, Boutron-Ruault MC, Kvaskoff M, Dossus L, Johansson M, Boeing H, Trichopoulou A, Benetou V, La Vecchia C, Sieri S, Mattiello A, Palli D, Tumino R, Matullo G, Onland-Moret NC, Gram IT, Weiderpass E, Sánchez MJ, Navarro Sanchez C, Duell EJ, Ardanaz E, Larranaga N, Lundin E, Idahl A, Jirström K, Nodin B, Travis RC, Riboli E, Merritt M, Aune D, Terry K, Cramer DW, Anderson KS.

Int J Cancer. 2018 Aug 1;143(3):515-526. doi: 10.1002/ijc.31335. Epub 2018 Mar 8.

PMID:
29473162
11.

From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection.

Kudalkar SN, Beloor J, Quijano E, Spasov KA, Lee WG, Cisneros JA, Saltzman WM, Kumar P, Jorgensen WL, Anderson KS.

Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):E802-E811. doi: 10.1073/pnas.1717932115. Epub 2017 Dec 26. Erratum in: Proc Natl Acad Sci U S A. 2018 Mar 12;:.

PMID:
29279368
12.

Modeling the Subclonal Evolution of Cancer Cell Populations.

Chowell D, Napier J, Gupta R, Anderson KS, Maley CC, Sayres MAW.

Cancer Res. 2018 Feb 1;78(3):830-839. doi: 10.1158/0008-5472.CAN-17-1229. Epub 2017 Nov 29.

PMID:
29187407
13.

Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer.

Ferdosi S, Rehder DS, Maranian P, Castle EP, Ho TH, Pass HI, Cramer DW, Anderson KS, Fu L, Cole DEC, Le T, Wu X, Borges CR.

J Proteome Res. 2018 Jan 5;17(1):543-558. doi: 10.1021/acs.jproteome.7b00672. Epub 2017 Nov 21.

PMID:
29129073
14.

Serum Immune Profiling for Early Detection of Cervical Disease.

Ewaisha R, Panicker G, Maranian P, Unger ER, Anderson KS.

Theranostics. 2017 Aug 23;7(16):3814-3823. doi: 10.7150/thno.21098. eCollection 2017.

15.

Discussion of: "The success of sentinel lymph node biopsy after neoadjuvant therapy: A single institution review".

Chang JM, Kosiorek HE, Wasif N, Gray RJ, Stucky CH, Northfelt DW, Anderson KS, McCullough AE, Tolgay Ocal I, Pockaj BA.

Am J Surg. 2017 Dec;214(6):1102-1103. doi: 10.1016/j.amjsurg.2017.09.024. Epub 2017 Sep 30. No abstract available.

PMID:
29037421
16.

The success of sentinel lymph node biopsy after neoadjuvant therapy: A single institution review.

Chang JM, Kosiorek HE, Wasif N, Gray RJ, Stucky CH, Northfelt DW, Anderson KS, McCullough AE, Ocal IT, Pockaj BA.

Am J Surg. 2017 Dec;214(6):1096-1101. doi: 10.1016/j.amjsurg.2017.08.024. Epub 2017 Sep 18.

PMID:
28943062
17.

Pre-diagnostic dynamic HPV16 IgG seropositivity and risk of oropharyngeal cancer.

Anderson KS, Wallstrom G, Langseth H, Posner M, Cheng JN, Alam R, Chowell D, Furre IE, Mork J.

Oral Oncol. 2017 Oct;73:132-137. doi: 10.1016/j.oraloncology.2017.08.014. Epub 2017 Sep 1.

PMID:
28939065
18.

Classifying the evolutionary and ecological features of neoplasms.

Maley CC, Aktipis A, Graham TA, Sottoriva A, Boddy AM, Janiszewska M, Silva AS, Gerlinger M, Yuan Y, Pienta KJ, Anderson KS, Gatenby R, Swanton C, Posada D, Wu CI, Schiffman JD, Hwang ES, Polyak K, Anderson ARA, Brown JS, Greaves M, Shibata D.

Nat Rev Cancer. 2017 Oct;17(10):605-619. doi: 10.1038/nrc.2017.69. Epub 2017 Sep 15. Review.

19.

Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.

Dahlstrom KR, Anderson KS, Field MS, Chowell D, Ning J, Li N, Wei Q, Li G, Sturgis EM.

Cancer. 2017 Dec 15;123(24):4886-4894. doi: 10.1002/cncr.30955. Epub 2017 Sep 12.

PMID:
28898394
20.

Covalent inhibitors for eradication of drug-resistant HIV-1 reverse transcriptase: From design to protein crystallography.

Chan AH, Lee WG, Spasov KA, Cisneros JA, Kudalkar SN, Petrova ZO, Buckingham AB, Anderson KS, Jorgensen WL.

Proc Natl Acad Sci U S A. 2017 Sep 5;114(36):9725-9730. doi: 10.1073/pnas.1711463114. Epub 2017 Aug 21.

21.

Development and validation of a novel clinical fluorescence in situ hybridization assay to detect JAK2 and PD-L1 amplification: a fluorescence in situ hybridization assay for JAK2 and PD-L1 amplification.

Chen M, Andreozzi M, Pockaj B, Barrett MT, Ocal IT, McCullough AE, Linnaus ME, Chang JM, Yearley JH, Annamalai L, Anderson KS.

Mod Pathol. 2017 Nov;30(11):1516-1526. doi: 10.1038/modpathol.2017.86. Epub 2017 Jul 28.

PMID:
28752839
22.

Isolation, Detection, and Quantification of Cancer Biomarkers in HPV-Associated Malignancies.

Inan H, Wang S, Inci F, Baday M, Zangar R, Kesiraju S, Anderson KS, Cunningham BT, Demirci U.

Sci Rep. 2017 Jun 12;7(1):3322. doi: 10.1038/s41598-017-02672-6.

23.

Notes from the Field: Veillonella Misidentified as Francisella tularensis - Idaho, 2016.

Carter KK, Peterson EM, Voermans RL, Anderson KS 3rd, Cox T, Kassem AM, Ball CL, Hahn CG.

MMWR Morb Mortal Wkly Rep. 2017 Jun 2;66(21):564-565. doi: 10.15585/mmwr.mm6621a4. No abstract available.

24.

MYB fusions and CD markers as tools for authentication and purification of cancer stem cells from salivary adenoid cystic carcinoma.

Panaccione A, Zhang Y, Ryan M, Moskaluk CA, Anderson KS, Yarbrough WG, Ivanov SV.

Stem Cell Res. 2017 May;21:160-166. doi: 10.1016/j.scr.2017.05.002. Epub 2017 May 5.

25.

A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study.

Monk BJ, Brady MF, Aghajanian C, Lankes HA, Rizack T, Leach J, Fowler JM, Higgins R, Hanjani P, Morgan M, Edwards R, Bradley W, Kolevska T, Foukas P, Swisher EM, Anderson KS, Gottardo R, Bryan JK, Newkirk M, Manjarrez KL, Mannel RS, Hershberg RM, Coukos G.

Ann Oncol. 2017 May 1;28(5):996-1004. doi: 10.1093/annonc/mdx049.

26.

Autoantibody biomarkers for the detection of serous ovarian cancer.

Katchman BA, Chowell D, Wallstrom G, Vitonis AF, LaBaer J, Cramer DW, Anderson KS.

Gynecol Oncol. 2017 Jul;146(1):129-136. doi: 10.1016/j.ygyno.2017.04.005. Epub 2017 Apr 18.

27.

Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma.

Hanna GJ, Sridharan V, Margalit DN, La Follette SK, Chau NG, Rabinowits G, Lorch JH, Haddad RI, Tishler RB, Anderson KS, Schoenfeld JD.

Cancer Biomark. 2017;19(2):129-136. doi: 10.3233/CBM-160071.

PMID:
28387659
28.

Understanding the molecular mechanism of substrate channeling and domain communication in protozoal bifunctional TS-DHFR.

Anderson KS.

Protein Eng Des Sel. 2017 Mar 1;30(3):253-261. doi: 10.1093/protein/gzx004. Review.

PMID:
28338744
29.

NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer.

Ma CX, Gao F, Luo J, Northfelt DW, Goetz M, Forero A, Hoog J, Naughton M, Ademuyiwa F, Suresh R, Anderson KS, Margenthaler J, Aft R, Hobday T, Moynihan T, Gillanders W, Cyr A, Eberlein TJ, Hieken T, Krontiras H, Guo Z, Lee MV, Spies NC, Skidmore ZL, Griffith OL, Griffith M, Thomas S, Bumb C, Vij K, Bartlett CH, Koehler M, Al-Kateb H, Sanati S, Ellis MJ.

Clin Cancer Res. 2017 Aug 1;23(15):4055-4065. doi: 10.1158/1078-0432.CCR-16-3206. Epub 2017 Mar 7.

30.

Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection.

Kudalkar SN, Beloor J, Chan AH, Lee WG, Jorgensen WL, Kumar P, Anderson KS.

Mol Pharmacol. 2017 Apr;91(4):383-391. doi: 10.1124/mol.116.107755. Epub 2017 Feb 6.

31.

Prepubertal ovariectomy modulates paced mating behavior but not sexual preference or conditioned place preference for mating in female rats.

Meerts SH, Anderson KS, Farry-Thorn ME, Johnson EG, Taxier L.

Physiol Behav. 2017 Mar 15;171:142-148. doi: 10.1016/j.physbeh.2017.01.012. Epub 2017 Jan 9.

PMID:
28082246
32.

Design, Conformation, and Crystallography of 2-Naphthyl Phenyl Ethers as Potent Anti-HIV Agents.

Lee WG, Chan AH, Spasov KA, Anderson KS, Jorgensen WL.

ACS Med Chem Lett. 2016 Oct 31;7(12):1156-1160. eCollection 2016 Dec 8.

33.

Human Papillomavirus-Associated Oropharyngeal Cancer: Not Just White Men Anymore.

Dahlstrom KR, Anderson KS, Sturgis EM.

JAMA Oncol. 2016 Dec 8. doi: 10.1001/jamaoncol.2016.3510. [Epub ahead of print] No abstract available.

PMID:
27930755
34.

Genome-wide gene-environment interaction analysis of pesticide exposure and risk of Parkinson's disease.

Biernacka JM, Chung SJ, Armasu SM, Anderson KS, Lill CM, Bertram L, Ahlskog JE, Brighina L, Frigerio R, Maraganore DM.

Parkinsonism Relat Disord. 2016 Nov;32:25-30. doi: 10.1016/j.parkreldis.2016.08.002. Epub 2016 Aug 3.

35.

The DNA Polymerase Gamma R953C Mutant Is Associated with Antiretroviral Therapy-Induced Mitochondrial Toxicity.

Li M, Mislak AC, Foli Y, Agbosu E, Bose V, Bhandari S, Szymanski MR, Shumate CK, Yin YW, Anderson KS, Paintsil E.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5608-11. doi: 10.1128/AAC.00976-16. Print 2016 Sep.

36.

Application of flat panel OLED display technology for the point-of-care detection of circulating cancer biomarkers.

Katchman BA, Smith JT, Obahiagbon U, Kesiraju S, Lee YK, O'Brien B, Kaftanoglu K, Blain Christen J, Anderson KS.

Sci Rep. 2016 Jul 4;6:29057. doi: 10.1038/srep29057.

37.

Proteomic mapping of p53 immunogenicity in pancreatic, ovarian, and breast cancers.

Katchman BA, Barderas R, Alam R, Chowell D, Field MS, Esserman LJ, Wallstrom G, LaBaer J, Cramer DW, Hollingsworth MA, Anderson KS.

Proteomics Clin Appl. 2016 Jul;10(7):720-31. doi: 10.1002/prca.201500096. Epub 2016 May 17.

38.

Programmable protein arrays for immunoprofiling HPV-associated cancers.

Ewaisha R, Meshay I, Resnik J, Katchman BA, Anderson KS.

Proteomics. 2016 Apr;16(8):1215-24. doi: 10.1002/pmic.201500376. Epub 2016 Apr 4.

39.

T-Cell Epitope Discovery for Therapeutic Cancer Vaccines.

Krishna S, Anderson KS.

Methods Mol Biol. 2016;1403:779-96. doi: 10.1007/978-1-4939-3387-7_45.

PMID:
27076167
40.

Proteomic Monitoring of B Cell Immunity.

Ewaisha R, Anderson KS.

Methods Mol Biol. 2016;1403:131-52. doi: 10.1007/978-1-4939-3387-7_6.

41.

Data publication with the structural biology data grid supports live analysis.

Meyer PA, Socias S, Key J, Ransey E, Tjon EC, Buschiazzo A, Lei M, Botka C, Withrow J, Neau D, Rajashankar K, Anderson KS, Baxter RH, Blacklow SC, Boggon TJ, Bonvin AM, Borek D, Brett TJ, Caflisch A, Chang CI, Chazin WJ, Corbett KD, Cosgrove MS, Crosson S, Dhe-Paganon S, Di Cera E, Drennan CL, Eck MJ, Eichman BF, Fan QR, Ferré-D'Amaré AR, Fromme JC, Garcia KC, Gaudet R, Gong P, Harrison SC, Heldwein EE, Jia Z, Keenan RJ, Kruse AC, Kvansakul M, McLellan JS, Modis Y, Nam Y, Otwinowski Z, Pai EF, Pereira PJ, Petosa C, Raman CS, Rapoport TA, Roll-Mecak A, Rosen MK, Rudenko G, Schlessinger J, Schwartz TU, Shamoo Y, Sondermann H, Tao YJ, Tolia NH, Tsodikov OV, Westover KD, Wu H, Foster I, Fraser JS, Maia FR, Gonen T, Kirchhausen T, Diederichs K, Crosas M, Sliz P.

Nat Commun. 2016 Mar 7;7:10882. doi: 10.1038/ncomms10882.

42.

Crucial considerations for pipelines to validate circulating biomarkers for breast cancer.

Ewaisha R, Gawryletz CD, Anderson KS.

Expert Rev Proteomics. 2016;13(2):201-11. doi: 10.1586/14789450.2016.1132170. Epub 2016 Jan 4. Review.

PMID:
26653344
43.

Regional recurrence in the era of sentinel lymph node biopsy.

Linnaus ME, Dueck AC, Kosiorek HE, Gray RJ, Wasif N, Northfelt DW, Anderson KS, McCullough AE, Wong WW, Halyard MY, Patel SH, Pockaj BA.

Am J Surg. 2015 Dec;210(6):1155-60; discussion 1160-1. doi: 10.1016/j.amjsurg.2015.09.001. Epub 2015 Sep 28.

PMID:
26601646
44.

Insights into the Molecular Mechanism of Polymerization and Nucleoside Reverse Transcriptase Inhibitor Incorporation by Human PrimPol.

Mislak AC, Anderson KS.

Antimicrob Agents Chemother. 2015 Nov 9;60(1):561-9. doi: 10.1128/AAC.02270-15. Print 2016 Jan.

45.

Potent Inhibitors Active against HIV Reverse Transcriptase with K101P, a Mutation Conferring Rilpivirine Resistance.

Gray WT, Frey KM, Laskey SB, Mislak AC, Spasov KA, Lee WG, Bollini M, Siliciano RF, Jorgensen WL, Anderson KS.

ACS Med Chem Lett. 2015 Aug 31;6(10):1075-9. doi: 10.1021/acsmedchemlett.5b00254. eCollection 2015 Oct 8.

46.

Endoscopic overestimation of colorectal polyp size.

Anderson BW, Smyrk TC, Anderson KS, Mahoney DW, Devens ME, Sweetser SR, Kisiel JB, Ahlquist DA.

Gastrointest Endosc. 2016 Jan;83(1):201-8. doi: 10.1016/j.gie.2015.06.058. Epub 2015 Aug 28.

PMID:
26318830
47.

Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer.

Barrett MT, Anderson KS, Lenkiewicz E, Andreozzi M, Cunliffe HE, Klassen CL, Dueck AC, McCullough AE, Reddy SK, Ramanathan RK, Northfelt DW, Pockaj BA.

Oncotarget. 2015 Sep 22;6(28):26483-93. doi: 10.18632/oncotarget.4494.

48.

Discovery and crystallography of bicyclic arylaminoazines as potent inhibitors of HIV-1 reverse transcriptase.

Lee WG, Frey KM, Gallardo-Macias R, Spasov KA, Chan AH, Anderson KS, Jorgensen WL.

Bioorg Med Chem Lett. 2015 Nov 1;25(21):4824-4827. doi: 10.1016/j.bmcl.2015.06.074. Epub 2015 Jul 9.

49.

Probing the structural and molecular basis of nucleotide selectivity by human mitochondrial DNA polymerase γ.

Sohl CD, Szymanski MR, Mislak AC, Shumate CK, Amiralaei S, Schinazi RF, Anderson KS, Yin YW.

Proc Natl Acad Sci U S A. 2015 Jul 14;112(28):8596-601. doi: 10.1073/pnas.1421733112. Epub 2015 Jun 29. Erratum in: Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):E662.

50.

Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT study.

Anderson KS, Gerber JE, D'Souza G, Pai SI, Cheng JN, Alam R, Kesiraju S, Chowell D, Gross ND, Haddad R, Gillison ML, Posner M.

Oral Oncol. 2015 Aug;51(8):751-8. doi: 10.1016/j.oraloncology.2015.05.007. Epub 2015 Jun 18.

Supplemental Content

Loading ...
Support Center